MedTrace Logo

CNAP vs IABP in Pregnant Women With Placenta Accreta

NCT04671680 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-10-21

No results posted yet for this study

Summary

The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the investigators plan to conduct a prospective, observational study with the following aims:

Specific Aim 1: Compare concordance between the systolic (SBP), diastolic (DBP), and mean arterial blood pressure (MAP) readings from the continuous non-invasive arterial blood pressure (CNAP) and IABP at several discrete points throughout the procedure

Specific Aim 2: Determine the feasibility of using CNAP to aid in decision making by examining the parameters of volume responsiveness and arterial elastance at several discrete points throughout the procedure.

The investigators hypothesize that the investigators can obtain similar blood pressure monitoring using CNAP as compared to the gold standard IABP in women undergoing cesarean delivery with suspected placenta accreta.

Conditions

  • Placenta Accreta
  • Blood Pressure
  • Hemorrhage
  • Hemorrhage, Postpartum

Interventions

DEVICE

LiDCO CNAP Monitoring Equipment

A continuous non-invasive arterial blood pressure monitor for rapidly changing hemodynamics.

Sponsors & Collaborators

Principal Investigators

  • John J. Kowalczyk, MD · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-15
Primary Completion
2025-06-01
Completion
2025-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04671680 on ClinicalTrials.gov